Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × rhenium-SSS-lipiodol × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatocellular Carcinoma Non-resectable 1

Interventions

pembrolizumab 529 Cyclophosphamide 490 Magnetic Resonance Spectroscopy 459 Radiotherapy 441 Specimen Handling 434 Nivolumab 381 Carboplatin 327 Cisplatin 322 Biopsy 264 Blood Specimen Collection 260 Radiosurgery 254 Paclitaxel 248 Dexamethasone 239 Standard of Care 234 Gemcitabine 232 venetoclax 231 Drug Therapy 228 Surveys and Questionnaires 227 fludarabine 224 Bevacizumab 213 Rituximab 188 Oxaliplatin 186 Radiation 179 Ipilimumab 179 Fluorouracil 178 Capecitabine 174 durvalumab 163 Doxorubicin 160 atezolizumab 159 Docetaxel 148

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05797870 2026-03-19

Lip-Re2

Center Eugene Marquis

Phase 2 Suspended

Gastrointestinal

Hepatocellular Carcinoma Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡